• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Long ‐term follow‐up after PFO device closure
ConclusionsDevice closure of PFO can be performed safely with very good long‐term resolution of atrial shunting. Recurrent neurologic events after PFO closure may reflect additional comorbid risk factors unrelated to the potential for paradoxical embolism. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 28, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Nathaniel W. Taggart, Guy S. Reeder, Ryan J. Lennon, Joshua P. Slusser, Monique A. Freund, Allison K. Cabalka, Frank Cetta, Donald J. Hagler Tags: Valvular and Structural Heart Diseases Source Type: research

Life in the left atrial appendage fast lane after FDA approval: Moving forward on new technology at last
Key Points FDA approval of the WATCHMAN is expected to spur development and availability of a range of evolutionary and revolutionary technologies for left atrial appendage occlusion. The fourth generation WATCHMAN described in this article has multiple features that will potentially streamline the deployment process and have the potential to make left atrial appendage occlusion safer. The population studied was too small to compare the relatively high adverse event rate with the known outcomes associated with existing WATCHMAN technology. Going forward, in part because of improvements in technology, it is likely that lat...
Source: Catheterization and Cardiovascular Interventions - March 15, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Zoltan G Turi Tags: Valvular and Structural Heart Diseases Source Type: research

The outcomes of transcatheter aortic valve replacement in a cohort of patients with end‐stage renal disease
ConclusionsPatients with ESRD who undergo TAVR are at high risk for mortality and complications. TAVR outcomes are comparable to but not substantially better than those with SAVR. Transfemoral TAVR seems to be at least as safe and effective as the current standard SAVR in patients undergoing aortic valve replacement. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 4, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Molly Szerlip, Rebeca J. Kim, Tokunbo Adeniyi, Vinod Thourani, Vasilis Babaliaros, Joseph Bavaria, Howard C. Herrmann, Saif Anwaruddin, Raj Makkar, Tarun Chakravarty, Joshua Rovin, Don Creighton, D. Craig Miller, Kim Baio, Elizabeth Walsh, Jasmina Katinic Tags: Valvular and Structural Heart Diseases Source Type: research

Efficacy and safety of transcatheter aortic valve replacement in intermediate surgical risk patients: A systematic review and meta‐analysis
ConclusionsIn this meta‐analysis we found that TAVR may be an acceptable alternative to SAVR in patients with intermediate risk for surgery. However, we must await evidence from the current large randomized trials before widespread adoption of this procedure is undertaken. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 4, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Abdur Rahman Khan, Sobia Khan, Haris Riaz, Faraz Khan Luni, Herman Simo, Aref Bin Abdulhak, Chirag Bavishi, Michael Flaherty Tags: Valvular and Structural Heart Diseases Source Type: research

Stenting of the left pulmonary artery after palliation of hypoplastic left heart syndrome
ConclusionsStenting of the left pulmonary artery after Norwood/Fontan palliation is safe and effective. Stents can be redilated to match somatic growth. The incidence of neointimal proliferation is extremely low and can be addressed by balloon dilation or stent implantation. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - February 24, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Patrick Noonan, Vikram Kudumula, Ben Anderson, Bharat Ramchandani, Paul Miller, Rami Dhillon, Chetan Mehta, Oliver Stumper Tags: Pediatric and Congenital Heart Disease Source Type: research

The interval between carotid artery stenting and open heart surgery is related to perioperative complications
ConclusionsOur findings indicate that CAS followed by OHS is safe and feasible. More importantly, an interval between CAS and OHS of >5 days may decrease periprocedural complications, especially major stroke and neurological death. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - January 26, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Hui Dong, Xiongjing Jiang, Meng Peng, Yubao Zou, Wuqiang Che, Haiyan Qian, Bo Xu, Lei Song, Yuejin Yang, Runlin Gao Tags: Peripheral Vascular Disease Source Type: research

SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio‐oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologıa intervencionista)
In the United States alone, there are currently approximately 14.5 million cancer survivors, and this number is expected to increase to 20 million by 2020. Cancer therapies can cause significant injury to the vasculature, resulting in angina, acute coronary syndromes (ACS), stroke, critical limb ischemia, arrhythmias, and heart failure, independently from the direct myocardial or pericardial damage from the malignancy itself. Consequently, the need for invasive evaluation and management in the cardiac catheterization laboratory (CCL) for such patients has been increasing. In recognition of the need for a document on specia...
Source: Catheterization and Cardiovascular Interventions - January 12, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Cezar A. Iliescu, Cindy L. Grines, Joerg Herrmann, Eric H. Yang, Mehmet Cilingiroglu, Konstantinos Charitakis, Abdul Hakeem, Konstantinos P. Toutouzas, Massoud A. Leesar, Konstantinos Marmagkiolis Tags: Coronary Artery Disease Source Type: research

EWOLUTION: Design of a registry to evaluate real‐world clinical outcomes in patients with AF and high stroke risk‐treated with the WATCHMAN left atrial appendage closure technology
ConclusionThe EWOLUTION study will formally expand knowledge of LAA closure into a broader real world setting. © 2015 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - December 31, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Lucas V.A. Boersma, Boris Schmidt, Tim R. Betts, Horst Sievert, Corrado Tamburino, Emmanuel Teiger, Kenneth M. Stein, Martin W. Bergmann Tags: Valvular and Structural Heart Diseases Source Type: research

EWOLUTION: Design of a registry to evaluate real ‐world clinical outcomes in patients with AF and high stroke risk‐treated with the WATCHMAN left atrial appendage closure technology
ConclusionThe EWOLUTION study will formally expand knowledge of LAA closure into a broader real world setting. © 2015 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - December 30, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Lucas V.A. Boersma, Boris Schmidt, Tim R. Betts, Horst Sievert, Corrado Tamburino, Emmanuel Teiger, Kenneth M. Stein, Martin W. Bergmann Tags: Valvular and Structural Heart Diseases Source Type: research

Transcatheter valve‐in‐ring implantation of a repositionable valve system for treatment of severe mitral regurgitation
ConclusionTransapical valve‐in‐ring implantation of the repositionable Lotus valve system in the mitral position is a feasible and promising option that merits further evaluation. © 2015 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - December 23, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Michael Lauterbach, Bruno Sontag, Alexandros Paraforos, Ivar Friedrich, Karl‐Eugen Hauptmann Tags: Valvular and Structural Heart Diseases Source Type: research

SCAI expert consensus statement—executive summary evaluation, management, and special considerations of cardio‐oncology patients in the cardiac catheterization laboratory
In the United States alone, there are currently approximately 14.5 million cancer survivors, and this number is expected to increase to 20 million by 2020. Cancer therapies can cause significant injury to the vasculature, resulting in angina, acute coronary syndromes (ACS), stroke, critical limb ischemia, arrhythmias, and heart failure, independently from the direct myocardial or pericardial damage from the malignancy itself. Consequently, the need for invasive evaluation and management in the cardiac catheterization laboratory (CCL) for such patients has been increasing. In recognition of the need for a document on specia...
Source: Catheterization and Cardiovascular Interventions - December 23, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Cezar Iliescu, Cindy L. Grines, Joerg Herrmann, Eric H. Yang, Mehmet Cilingiroglu, Konstantinos Charitakis, Abdul Hakeem, Konstantinos Toutouzas, Massoud A. Leesar, Konstantinos Marmagkiolis Tags: Coronary Artery Disease Source Type: research

Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar
ConclusionsTransradial access was associated with lower bleeding rates and similar long‐term ischemic outcomes, suggesting transradial access is safer than transfemoral access among ACS patients receiving potent antiplatelet therapies. Because of the nonrandomized allocation of arterial access, these results should be considered exploratory. © 2015 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - December 23, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Jean‐Pierre Déry, Kenneth W. Mahaffey, Pierluigi Tricoci, Harvey D. White, Mohua Podder, Cynthia M. Westerhout, David J. Moliterno, Robert A. Harrington, Edmond Chen, John Strony, Frans Van de Werf, Khaled M. Ziada, Claes Held, Philip E. Aylward, Paul Tags: Coronary Artery Disease Source Type: research

Meta‐analysis of randomized controlled trials comparing percutaneous coronary intervention with aspiration thrombectomy Vs. Conventional percutaneous coronary intervention during ST‐segment elevation myocardial infarction
ConclusionsUsing the totality of evidence available through 2015, this meta‐analysis failed to show that the routine use of aspiration thrombectomy in patients with ST‐elevation myocardial infarction significantly reduces all‐cause mortality, MACE, recurrent MI, TVR, or stent thrombosis. The role of aspiration thrombectomy in selected patients with angiographic evidence of large thrombus burden requires further clinical investigation. © 2015 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - December 23, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Abel Casso Dominguez, John A. Bittl, Georges El‐Hayek, Elizabeth Contreras, Jacqueline E. Tamis‐Holland Tags: Coronary Artery Disease Source Type: research

SCAI expert consensus statement: Evaluation, management, and special considerations of cardio‐oncology patients in the cardiac catheterization laboratory (Endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologıa Intervencionista)
In the United States alone, there are currently approximately 14.5 million cancer survivors, and this number is expected to increase to 20 million by 2020. Cancer therapies can cause significant injury to the vasculature, resulting in angina, acute coronary syndromes (ACS), stroke, critical limb ischemia, arrhythmias, and heart failure, independently from the direct myocardial or pericardial damage from the malignancy itself. Consequently, the need for invasive evaluation and management in the cardiac catheterization laboratory (CCL) for such patients has been increasing. In recognition of the need for a document on specia...
Source: Catheterization and Cardiovascular Interventions - December 23, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Cezar Iliescu, Cindy L. Grines, Joerg Herrmann, Eric H. Yang, Mehmet Cilingiroglu, Konstantinos Charitakis, Abdul Hakeem, Konstantinos Toutouzas, Massoud A. Leesar, Konstantinos Marmagkiolis Tags: Coronary Artery Disease Source Type: research

Transcatheter valve ‐in‐ring implantation of a repositionable valve system for treatment of severe mitral regurgitation
ConclusionTransapical valve‐in‐ring implantation of the repositionable Lotus valve system in the mitral position is a feasible and promising option that merits further evaluation. © 2015 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - December 22, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Michael Lauterbach, Bruno Sontag, Alexandros Paraforos, Ivar Friedrich, Karl ‐Eugen Hauptmann Tags: E ‐Only: Valvular and Structural Heart Diseases Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10